• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY Back to Search Results
Model Number D160901
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Stroke/CVA (1770)
Event Date 07/27/2022
Event Type  Injury  
Event Description
It was reported that an unknown male patient underwent a persistent atrial fibrillation (afib) ablation procedure with a octaray, perseid, 48p, 2-2-2-2-2, d-curve and a thermocool® smart touch® sf bi-directional navigation catheter.The patient experienced double images and suffered cerebral ischemic lesions after and ablation procedure.The patient reported he sees double images after pulmonary vein isolation (pvi) procedure with octaray.Physician performed a mrt and ct.He found sub-acute cerebral ischemic lesions.A smarttouch sf (df d134805) ablation catheter was used; but physician supposed that the octaray (d160901) catheter could be the cause.This adverse event was discovered post use of biosense webster products.The physician has no idea where the cause came from.It could be the catheter or the patient's health constitution.However, the temporal relationship to the examination is striking.Intervention being provided was afib pvi.The patient required extended hospitalization because of the adverse event for observation.A osypka hat 500® generator system was used.Conservatively the smart touch and octaray will be considered reportable as ablation was performed and the physician supposed that the octaray could be the cause so it is difficult to determine which device contributed to the event.This report is for the octaray.The smart touch was reported in manufacturer report number 2029046-2022-02013.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
 
Manufacturer Narrative
Initial reporter phone: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number, and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
On 15-sep-2022, bwi received additional information which clarified ¿the temporal relationship to the examination is striking".Clinical in charge stated that the night after the carto examination, patient was complaining about headache.An mri of the head was carried out during which the lesions were visible.It was also visible that the lesions were "fresh" (new).In terms of time-frame and type of intervention it is likely that this (i.E.The intervention) could have caused the issue / explains the noticed effect.Conservatively the smart touch and octaray will be considered reportable as ablation was performed and the physician supposed that the octaray could be the cause so it is difficult to determine which device contributed to the event.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OCTARAY MAPPING CATHETER
Type of Device
CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key15308464
MDR Text Key298772980
Report Number2029046-2022-02014
Device Sequence Number1
Product Code MTD
UDI-Device Identifier10846835021141
UDI-Public10846835021141
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K193237
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD160901
Device Catalogue NumberD160901
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/03/2022
Initial Date FDA Received08/29/2022
Supplement Dates Manufacturer Received09/15/2022
Supplement Dates FDA Received09/30/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
OSYPKA HAT 500® GENERATOR
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient SexMale
-
-